Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

YIjia Li

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
Biorxiv : the Preprint Server for Biology|July 3, 2026
Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic reboundDibya Ghimire, Chloe M Hasund, John Bianchi Colangeli, et al.
Open Forum Infectious Diseases|August 28, 2025
Immune Response to MVA-BN and Prior Smallpox Vaccination in People With HIV or at Risk for HIV AcquisitionYijia Li, Michael B Townsend, Shanshan Li, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
Nature Communications|August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19Kara W Chew, Carlee Moser, Eric S Daar, et al.
JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Biorxiv : the Preprint Server for Biology|July 3, 2026
Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic reboundDibya Ghimire, Chloe M Hasund, John Bianchi Colangeli, et al.
Open Forum Infectious Diseases|August 28, 2025
Immune Response to MVA-BN and Prior Smallpox Vaccination in People With HIV or at Risk for HIV AcquisitionYijia Li, Michael B Townsend, Shanshan Li, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
HIV post-treatment controllers have distinct immunological and virological featuresBehzad Etemad, Xiaoming Sun, Yijia Li, et al.
Nature Communications|August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19Kara W Chew, Carlee Moser, Eric S Daar, et al.
JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.
Nature Communications|October 31, 2020
SARS-CoV-2 viral load is associated with increased disease severity and mortalityJesse Fajnzylber, James Regan, Kendyll Coxen, et al.
Research Square|December 16, 2024
Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patientsSara V Patel, Brooke M Leeman, Patricia J Botros, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Pageof 22